Correlation Between CohBar and Kinnate Biopharma
Can any of the company-specific risk be diversified away by investing in both CohBar and Kinnate Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CohBar and Kinnate Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CohBar Inc and Kinnate Biopharma, you can compare the effects of market volatilities on CohBar and Kinnate Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CohBar with a short position of Kinnate Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of CohBar and Kinnate Biopharma.
Diversification Opportunities for CohBar and Kinnate Biopharma
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between CohBar and Kinnate is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding CohBar Inc and Kinnate Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kinnate Biopharma and CohBar is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CohBar Inc are associated (or correlated) with Kinnate Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kinnate Biopharma has no effect on the direction of CohBar i.e., CohBar and Kinnate Biopharma go up and down completely randomly.
Pair Corralation between CohBar and Kinnate Biopharma
If you would invest 296.00 in Kinnate Biopharma on September 28, 2024 and sell it today you would earn a total of 0.00 from holding Kinnate Biopharma or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
CohBar Inc vs. Kinnate Biopharma
Performance |
Timeline |
CohBar Inc |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Kinnate Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
CohBar and Kinnate Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with CohBar and Kinnate Biopharma
The main advantage of trading using opposite CohBar and Kinnate Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CohBar position performs unexpectedly, Kinnate Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kinnate Biopharma will offset losses from the drop in Kinnate Biopharma's long position.CohBar vs. Enveric Biosciences | CohBar vs. Elevation Oncology | CohBar vs. Hepion Pharmaceuticals | CohBar vs. Zura Bio Limited |
Kinnate Biopharma vs. ACELYRIN, INC Common | Kinnate Biopharma vs. Windtree Therapeutics | Kinnate Biopharma vs. Palisade Bio | Kinnate Biopharma vs. Century Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |